Laura Pitlik - Aug 16, 2022 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Marketing Officer
Signature
Laura Pitlik, by Attorney-in-Fact, Cesare Suardi
Stock symbol
RKDA
Transactions as of
Aug 16, 2022
Transactions value $
$0
Form type
4
Date filed
8/18/2022, 09:00 PM
Previous filing
Apr 13, 2022
Next filing
Apr 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (right to buy) Award $0 +23K +17.83% $0.00 152K Aug 16, 2022 Common Stock 23K $0.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in two equal installments occurring on the first, and second anniversary of the date of grant.

Remarks:

None